Smad6 Recruits Transcription Corepressor CtBP To Repress Bone Morphogenetic Protein-Induced Transcription

REFERENCES

• Afrakhte, M., A. Moren, S. Jossan, S. Itoh, K. Sampath, B. Westermark, C. H. Heldin, N. E. Heldin, and P. ten Dijke. 1998. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem. Biophys. Res. Commun. 249: 505–511.
   PubMed Web of Science ®Google Scholar
• Akiyoshi, S., H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono, and M. Kawabata. 1999. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with Smads. J. Biol. Chem. 274: 35269–35277.
   PubMed Web of Science ®Google Scholar
• Bai, S., and X. Cao. 2002. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-β signaling. J. Biol. Chem. 277: 4176–4182.
   PubMed Web of Science ®Google Scholar
• Bai, S., X. Shi, X. Yang, and X. Cao. 2000. Smad6 as a transcriptional corepressor. J. Biol. Chem. 275: 8267–8270.
   PubMedGoogle Scholar
• Blobe, G. C., W. P. Schiemann, and H. F. Lodish. 2000. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342: 1350–1358.
   PubMed Web of Science ®Google Scholar
• Boyd, J. M., T. Subramanian, U. Schaeper, M. La Regina, S. Bayley, and G. Chinnadurai. 1993. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12: 469–478.
   PubMed Web of Science ®Google Scholar
• Chinnadurai, G. 2002. CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 9: 213–224.
   PubMed Web of Science ®Google Scholar
• Dennler, S., M. J. Goumans, and P. Ten Dijke. 2002. Transforming growth factor β signal transduction. J. Leukoc. Biol. 71: 731–740.
   PubMed Web of Science ®Google Scholar
• Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29: 117–129.
   PubMed Web of Science ®Google Scholar
• Derynck, R., and X.-H. Feng. 1997. TGF-β receptor signaling. Biochim. Biophys. Acta 1333: F105–F150.
   PubMed Web of Science ®Google Scholar
• Derynck, R., Y. Zhang, and X. H. Feng. 1998. Smads: transcriptional activators of TGF-β responses. Cell 95: 737–740.
   PubMed Web of Science ®Google Scholar
• Feng, X.-H., Y.-Y. Liang, M. Liang, W. Zhai, and X. Lin. 2002. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-β-mediated induction of the CDK inhibitor p15INK4B. Mol. Cell 9: 133–143.
   PubMed Web of Science ®Google Scholar
• Feng, X.-H., X. Lin, and R. Derynck. 2000. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β. EMBO J. 19: 5178–5193.
   PubMed Web of Science ®Google Scholar
• Feng, X.-H., Y. Zhang, R.-Y. Wu, and R. Derynck. 1998. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation. Genes Dev. 12: 2153–2163.
   PubMedGoogle Scholar
• Feng, X. H., E. H. Filvaroff, and R. Derynck. 1995. Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. Characterization of chimeric and truncated type I and type II receptors. J. Biol. Chem. 270: 24237–24245.
   PubMed Web of Science ®Google Scholar
• Hanyu, A., Y. Ishidou, T. Ebisawa, T. Shimanuki, T. Imamura, and K. Miyazono. 2001. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling. J. Cell Biol. 155: 1017–1027.
   PubMed Web of Science ®Google Scholar
• Hata, A., G. Lagna, J. Massague, and A. Hemmati-Brivanlou. 1998. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12: 186–197.
   PubMedGoogle Scholar
• Imamura, T., M. Takase, A. Nishihara, E. Oeda, J. Hanai, M. Kawabata, and K. Miyazono. 1997. Smad6 inhibits signalling by the TGF-β superfamily. Nature 389: 622–626.
   PubMed Web of Science ®Google Scholar
• Izutsu, K., M. Kurokawa, Y. Imai, K. Maki, K. Mitani, and H. Hirai. 2001. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling. Blood 97: 2815–2822.
   PubMed Web of Science ®Google Scholar
• Katagiri, T., M. Imada, T. Yanai, T. Suda, N. Takahashi, and R. Kamijo. 2002. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7: 949–960.
   PubMed Web of Science ®Google Scholar
• Korchynskyi, O., and P. ten Dijke. 2002. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277: 4883–4891.
   PubMed Web of Science ®Google Scholar
• Liberati, N. T., M. Moniwa, A. J. Borton, J. R. Davie, and X. F. Wang. 2001. An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity. J. Biol. Chem. 276: 22595–22603.
   PubMedGoogle Scholar
• Lopez-Rovira, T., E. Chalaux, J. Massague, J. L. Rosa, and F. Ventura. 2002. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J. Biol. Chem. 277: 3176–3185.
   PubMed Web of Science ®Google Scholar
• Luo, K., S. L. Stroschein, W. Wang, D. Chen, E. Martens, S. Zhou, and Q. Zhou. 1999. The Ski oncoprotein interacts with the Smad proteins to repress TGF-β signaling. Genes Dev. 13: 2196–2206.
   PubMed Web of Science ®Google Scholar
• Massagué, J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell. Biol. 1: 169–178.
   PubMed Web of Science ®Google Scholar
• Massagué, J., S. Blain, and R. Lo. 2000. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103: 295–309.
   PubMed Web of Science ®Google Scholar
• Massagué, J., and D. Wotton. 2000. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19: 1745–1754.
   PubMed Web of Science ®Google Scholar
• Melhuish, T. A., and D. Wotton. 2000. The interaction of the carboxyl terminus-binding protein with the Smad corepressor TGIF is disrupted by a holoprosencephaly mutation in TGIF. J. Biol. Chem. 275: 39762–39766.
   PubMed Web of Science ®Google Scholar
• Miyazono, K., K. Kusanagi, and H. Inoue. 2001. Divergence and convergence of TGF-β/BMP signaling. J. Cell. Physiol. 187: 265–276.
   PubMed Web of Science ®Google Scholar
• Miyazono, K., and K. Miyazawa. 2002. Id: a target of BMP signaling. Sci. STKE 2002: E40.
   Google Scholar
• Moustakas, A., S. Souchelnytskyi, and C. H. Heldin. 2001. Smad regulation in TGF-β signal transduction. J. Cell Sci. 114: 4359–4369.
   PubMed Web of Science ®Google Scholar
• Nakashima, K., T. Takizawa, W. Ochiai, M. Yanagisawa, T. Hisatsune, M. Nakafuku, K. Miyazono, T. Kishimoto, R. Kageyama, and T. Taga. 2001. BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc. Natl. Acad. Sci. USA 98: 5868–5873.
   PubMedGoogle Scholar
• Padgett, R., and G. Patterson. 2001. New developments for TGF-β. Dev. Cell 1: 343–349.
   PubMedGoogle Scholar
• Pulaski, L., M. Landstrom, C. H. Heldin, and S. Souchelnytskyi. 2001. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-β-dependent signaling but affects Smad7-dependent transcriptional activation. J. Biol. Chem. 276: 14344–4349.
   PubMed Web of Science ®Google Scholar
• Rich, J., A. Borton, and X. Wang. 2001. Transforming growth factor-β signaling in cancer. Microsc. Res. Tech. 52: 363–373.
   PubMedGoogle Scholar
• Roberts, A. B., and R. Derynck. 2001. Meeting report: signaling schemes for TGF-β. Sci. STKE 2001: PE43.
   PubMedGoogle Scholar
• Roberts, S. G. 2000. Mechanisms of action of transcription activation and repression domains. Cell. Mol. Life Sci. 57: 1149–1160.
   PubMed Web of Science ®Google Scholar
• Schaeper, U., J. M. Boyd, S. Verma, E. Uhlmann, T. Subramanian, and G. Chinnadurai. 1995. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. USA 92: 10467–10471.
   PubMed Web of Science ®Google Scholar
• Shi Y, J. Sawada, G. Sui, El B. Affar, J.R. Whetstine, F. Lan, H. Ogawa, M.P. Luke, Y. Nakatani, and Y. Shi. 2003. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422: 735–738.
   PubMedGoogle Scholar
• Sun, Y., X. Liu, E. Ng-Eaton, H. F. Lodish, and R. A. Weinberg. 1999. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor β signaling. Proc. Natl. Acad. Sci. USA 96: 12442–12447.
   PubMed Web of Science ®Google Scholar
• Takase, M., T. Imamura, T. K. Sampath, K. Takeda, H. Ichijo, K. Miyazono, and M. Kawabata. 1998. Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem. Biophys. Res. Commun. 244: 26–29.
   PubMedGoogle Scholar
• Topper, J., J. Cai, Y. Qiu, K. Anderson, Y.-Y. Xu, J. Deeds, R. Feeley, C. Gimeno, E. Woolf, O. Tayber, G. Mays, B. Sampson, F. Schoen, J. Gimbrone, and D. Falb. 1997. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA 94: 9314–9319.
   PubMed Web of Science ®Google Scholar
• Valdimarsdottir, G., M. J. Goumans, A. Rosendahl, M. Brugman, S. Itoh, F. Lebrin, P. Sideras, and P. Ten Dijke. 2002. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106: 2263–2270.
   PubMed Web of Science ®Google Scholar
• Wakefield, L. M., and A. B. Roberts. 2002. TGF-β signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12: 22–29.
   PubMed Web of Science ®Google Scholar
• Whitman, M., and M. Mercola. 2001. TGF-β superfamily signaling and left-right asymmetry. Sci. STKE 2001: RE1.
   PubMedGoogle Scholar
• Wotton, D., R. S. Lo, S. Lee, and J. Massague. 1999. A Smad transcriptional corepressor. Cell 97: 29–39.
   PubMed Web of Science ®Google Scholar
• Wrana, J. L. 2000. Regulation of Smad activity. Cell 100: 189–192.
   PubMedGoogle Scholar
• Xu, W., K. Angelis, D. Danielpour, M. M. Haddad, O. Bischof, J. Campisi, E. Stavnezer, and E. E. Medrano. 2000. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type β transforming growth factor. Proc. Natl. Acad. Sci. USA 97: 5924–5929.
   PubMedGoogle Scholar
• Zhang, C. L., T. A. McKinsey, J. R. Lu, and E. N. Olson. 2001. Association of COOH-terminal-binding protein and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J. Biol. Chem. 276: 35–39.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., D. W. Piston, and R. H. Goodman. 2002. Regulation of corepressor function by nuclear NADH. Science 295: 1895–1897.
   PubMed Web of Science ®Google Scholar
• Zhao, J., W. Shi, H. Chen, and D. Warburton. 2000. Smad7 and Smad6 differentially modulate transforming growth factor β-induced inhibition of embryonic lung morphogenesis. J. Biol. Chem. 275: 23992–23997.
   PubMedGoogle Scholar